Asset Search
Displaying all 2 assets.
-
Description Clinical Evolution Under Low-Dose Recombinant Interleukin 2 TreatmentA, Patient 3 at baseline (Severity of Alopecia Tool [SALT] score, 98); B, clinical evolution 6 months after the end of the...
Article Title: Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Publication Title: JAMA Dermatology -
Description Histological Results of Skin Biopsies Specimens of Lesional Scalp Obtained at Baseline, the Last Day of the Treatment, and 2 Months After the End of Treatment
Article Title: Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Publication Title: JAMA Dermatology
Displaying all 2 assets.